Literature DB >> 7101322

Comparison of cardiotoxicity of two anthracenediones and doxorubicin in rats.

G Zbinden, A K Beilstein.   

Abstract

Two new anthracenediones with antineoplastic activities resembling those of the anthracycline antibiotics were studied in a rat cardiotoxicity model system. NCS-196473 was approx. 10-fold less toxic than doxorubicin and caused only minor electrocardiogram (ECG) changes. Its dihydroxyanalog NSC-279836 was somewhat more toxic than doxorubicin, caused marked leukopenia and induced ECG changes and moderate elevation of serum GOT, LDH and creatine phosphokinase (CK). Both anthracenediones induced marked alterations of mitochondrial structure in the heart but no dilatation of the sarcoplasmic reticulum and distortion of the contractile elements. It is concluded that the cardiotoxic effects of the anthracenediones are of a less specific nature than those caused by doxorubicin.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7101322     DOI: 10.1016/0378-4274(82)90163-1

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  4 in total

Review 1.  Relapsed and refractory pediatric acute myeloid leukemia: current and emerging treatments.

Authors:  Jennifer Davila; Emily Slotkin; Thomas Renaud
Journal:  Paediatr Drugs       Date:  2014-04       Impact factor: 3.022

Review 2.  Mitoxantrone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer.

Authors:  D Faulds; J A Balfour; P Chrisp; H D Langtry
Journal:  Drugs       Date:  1991-03       Impact factor: 9.546

3.  Investigation of the interaction of cardiotoxic anticancer agents using the fetal mouse heart organ culture system.

Authors:  B F Kimler; R D Rethorst; G G Cox
Journal:  Invest New Drugs       Date:  1986       Impact factor: 3.850

4.  Plasma kinetics of mitoxantrone in leukemic patients.

Authors:  R Hulhoven; E Dumont; C Harvengt
Journal:  Med Oncol Tumor Pharmacother       Date:  1984
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.